Pneumococcal Polyvalent Vaccine Clinical Trials

2 actively recruiting trials across 2 locations

Also known as: PCV 23, PPSV, PPSV23, PPSV23 Vaccine, Pneumococcal 23-valent Polysaccharide Vaccine, Pneumococcal Polysaccharide Vaccine, Pneumococcal Vaccine Polyvalent, Pneumovax 23, Pnu-Imune 23

Filter by location:

Columbus, Ohio1 trial

Anti-pneumococcal Vaccine Strategy in Patients With Chronic Lymphocytic Leukemia

Ohio State University Comprehensive Cancer Center

Phase 2

Salt Lake City, Utah1 trial

Pneumococcal Pneumonia Vaccine Series (PCV20 and PPSV23) in Patients With Chronic Lymphocytic Leukemia Associated Immunodeficiency, PROTECT CLL Trial

Huntsman Cancer Institute/University of Utah

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.